CLINICAL_TRIALS
trial_result
· 2011-10-27
Clinical Trial Update: High-dose Prednisone in Duchenne Muscular Dystrophy [Phase 3]
Summary
Phase 3 trial update indicates completion of a high-dose prednisone study in Duchenne Muscular Dystrophy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cooperative International Neuromuscular Research Group | Conditions: Duchenne Muscular Dystrophy | Phase 3 | Status: COMPLETED